Introduction {#Sec1}
============

Peony root (PR) (Paeoniae Radix) is one of the most frequently used crude drugs in traditional Chinese medicine and Kampo medicine. In China there are two kinds of PR available---white peony root (WPR) and red peony root (RPR)---which are used for different remedies. WPR has been used to treat symptoms such as dizziness, limb spasm, abdominal pain, diarrhea, blood deficiency and irregular menses, etc. RPR, however, has been mainly used as remedies for blood stasis, gynecological diseases, cardiovascular illness, etc. \[[@CR1]\]. In Chinese Pharmacopoeia, WPR is prescribed as the root of *Paeonia lactiflora* Pallas, which has been boiled and peeled and RPR is prescribed as the naturally dried root of *P. lactiflora* and *P. veitchii* Lynch. With the exception of *P. veitchii*-derived RPR, the WPR and RPR are from the same botanical origin, *P. lactiflora*. The difference between WPR and RPR has been debated for a long time with regard to the processing methods (peeled or unpeeled), difference in flower colors or root colors, and cultivated or wild, etc. \[[@CR2]\]. The most recent Pharmacognosy textbook describes that WPR is derived from cultivated sources mainly produced in Anhui, Zhejiang, and Sichuan provinces of southern China, whereas RPR is derived from wild plants collected from Inner Mongolia and northeastern China \[[@CR3]\]. It is interesting to explore the underlying differences between these two crude drugs. It is also an appealing yet difficult task in terms of how to accurately discriminate between them. In this study, we attempted to find the answers using genetic and chemical approaches.

In the Japanese Pharmacopoeia, PR is prescribed as the root of *P. lactiflora* with not less than 2.0 % paeoniflorin \[[@CR4]\]. As an analgesic, antispasmodic, astringent, etc., it has been included in approximately one-third of Kampo formulas used in Japan \[[@CR5]\]. Hereafter, PR refers limitedly to the crude drugs of the roots of *P. lactiflora* available from Japanese markets. PR is supplied mainly by import from China and partly by domestic production, e.g., 1,188 tons was imported in 2010 and the domestic supply was 38 tons \[[@CR6]\]. Apart from the different processing methods, PR and WPR are considered to be almost the same crude drug, because both are derived from the cultivated *P. lactiflora*. Generally, the PR samples imported from China are produced in the same producing areas of WPR.

To date, genetic markers used in phylogenetic analysis of *Paeonia* species include nucleotide sequences of the ribosomal DNA internal transcribed spacer (ITS) region, Adh1/2 genes and GPAT gene of nDNA, as well as *mat*K gene, intergenic spacer *trn*L-F and *psb*A--*trn*H of cpDNA \[[@CR7]--[@CR10]\]. Among them, the ITS sequence has been demonstrated to be powerful for phylogenetic resolution and for discrimination between species due to the high rate of variation \[[@CR11], [@CR12]\]. Moreover, ITS sequencing of *Paeonia* species provides the most successful example of using the ITS sequence to reconstruct reticulate evolution; the nucleotide additivity is highly informative for detecting hybridization and inferring parental lineages \[[@CR7]\]. Phytochemical studies have indicated that *Paeonia* plants contain many bioactive components, including monoterpenes, flavonoids, phenols and tannins \[[@CR13]\]. Several reports have described quantitative analyses of the main chemical components of commercial samples of WPR and RPR \[[@CR14], [@CR15]\].

The present study determined the nucleotide sequence of the ITS region and conducted quantitative analysis of 8 main bioactive components on 4 *Paeonia* species, as well as commercial samples of PR, WPR and RPR collected from Japanese and Chinese markets to clarify the genetic and chemical characteristics of WPR and RPR.

Materials and methods {#Sec2}
=====================

Plant and crude drug materials {#Sec3}
------------------------------

Fourteen specimens of four *Paeonia* species were analyzed---*P. lactiflora*, *P. veitchii*, *P. anomala* Linn. and *P. japonica* Miyabe et Takeda. Details of the plant materials are shown in Table [1](#Tab1){ref-type="table"}. Meanwhile, 46 commercial samples available from Chinese and Japanese markets were collected and analyzed for comparison. Of the PR samples collected from Japanese markets, half were imported from China and half were produced in Japan. In several commercial samples, multiple individuals were analyzed and their identities were indicated separately. All of the plant specimens and crude drug samples were stored in the Museum of Materia Medica, Institute of Natural Medicine, University of Toyama, Japan (TMPW) (Table [2](#Tab2){ref-type="table"}).Table 1Plant specimens used in this studyOriginal plantLocation for collecting plantW/CVoucher no.Code no.Collection date*Paeonia lactiflora* PallasDuolun, Inner Mongolia, ChinaWWei S.L., 2007-1P1^a^2007.01.28*P. lactiflora*Arxan, Inner Mongolia, ChinaWMurakami M. MM-1P22007.08.11*P. lactiflora*Chifeng, Inner Mongolia, ChinaWKomatsu K. et al., HJN269P142012.08.04*P. lactiflora*Wudalianchi, Heilongjiang, ChinaWKomatsu K. et al., HJN143P152012.07.22*P. lactiflora*Wudalianchi, Heilongjiang, ChinaWKomatsu K. et al., HJN145P162012.07.22*P. lactiflora*MongoliaW623-63P31967*P. lactiflora*Xinwo, Zhejiang, ChinaCKomatsu K. et al., CJZ132P9^a^2009.08.05*P. lactiflora* (Bonten)Toyama, JapanCMurakami M., S34S34^a^2008.11.*P. lactiflora* (Kitasaisho)Toyama, JapanCMurakami M., S31S31^a^2008.11.*P. anomala* Linn.Tuluugiyn davas-Hutag-Ondor, Bulgan, MongoliaWKomatsu K. et al., M505P4^a^2002.07.20*P. anomala*Jingiin halzan-Bayannuul, Uvs, MongoliaWKomatsu K. et al., M755-1P5^a^2002.07.29*P. anomala*MongoliaWKomatsu K. et al., M755-2P6^a^2002.07.29*P. veitchii* LynchGanzi, Sichuan, ChinaWKomatsu K. et al., S-1P7^a^1996.07.10*P. japonica* Miyabe et TakedaToyama, JapanCMurakami M., MM-4P82008.12.04W, wild; C, cultivated^a^Samples used in chemical analysisTable 2Crude drug samples used in this studyDrug nameAbr.Production areaObtained fromCode no.Collection dateTMPW no.White peony rootWPRBozhou, Anhui, ChinaBozhou, Anhui, ChinaD1^a^2006.05.0225071White peony rootWPRBozhou, Anhui, ChinaBozhou, Anhui, ChinaD2^a^2006.05.0225072White peony rootWPRBozhou, Anhui, ChinaBozhou, Anhui, ChinaD3^a^2006.10.1725244White peony rootWPRBozhou, Anhui, ChinaBozhou, Anhui, ChinaD17^a^2006.05.0225073White peony rootWPRAnhui, ChinaHohhot, Inner Mongolia, China*D23* ^a^2010.10.1426975White peony rootWPRZhongjiang, Sichuan, ChinaJihuang, Zhongjiang, Sichuan, ChinaD4^a^2002.09.2325820White peony rootWPRZhejiang, ChinaCenxi, Guangxi, ChinaD18^a^2008.09.0625973White peony rootWPRHangzhou, Zhejiang, ChinaHohhot, Inner Mongolia, ChinaD22^a^2010.10.1326974White peony rootWPRPan'an, Zhejiang, ChinaPan'an, Zhejiang, ChinaD29^a^2009.08.0526620White peony rootWPRJiangsu, ChinaHohhot, Inner Mongolia, ChinaD24^a^2010.10.1626976Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD30201027685Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD31200927689Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD32200827690Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD33200827691Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD34200927693Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD35201027696Peony rootPRAnhui, ChinaNational Institute of Biomedical Innovation, JapanD36200927697Peony rootPRZhejiang, ChinaNational Institute of Biomedical Innovation, JapanD37201027686Peony rootPRSichuan, ChinaNational Institute of Biomedical Innovation, JapanD38200927687Peony rootPRSichuan, ChinaNational Institute of Biomedical Innovation, JapanD39200927692Peony rootPRSichuan, ChinaNational Institute of Biomedical Innovation, JapanD40Unknown27699Peony rootPRZhejiang, ChinaTochimoto Tenkaido Co., Ltd., Osaka, Japan*D45* ^a^2012.09.0427887Peony rootPRSichuan, ChinaTochimoto Tenkaido Co., Ltd., Osaka, Japan*D46* ^a^2012.09.0427888Peony rootPRAnhui, ChinaTochimoto Tenkaido Co., Ltd., Osaka, Japan*D47* ^a^2012.09.0427889Peony rootPRChinaUchida Wakanyaku Co., Ltd., Tokyo, Japan*D48* ^a^2012.09.0427890Peony rootPRChinaMatsuura Co., Ltd., Nagoya, JapanD53^a^2012.10.0427892Peony root (Bonten)PRToyama, JapanNara, JapanD50^a^2008.02.1525834Peony root (Bonten)PRToyama, JapanNara, JapanD51^a^2008.02.1525835Peony root (Bonten)PRToyama, JapanNara, JapanD52^a^2008.02.1525836Peony rootPRNiigata, JapanUchida Wakanyaku Co., Ltd., Tokyo, Japan*D6* ^a^2008.10.0726400Peony root (Yamato)PRNara, JapanTochimoto Tenkaido Co., Ltd., Osaka, JapanD7^a^2008.02.1425818Peony root (Yamato)PRHokkaido and Nagano, JapanTochimoto Tenkaido Co., Ltd., Osaka, JapanD8^a^2008.02.1425819Peony root (Yamato)PRNara, JapanTochimoto Tenkaido Co., Ltd., Osaka, JapanD9^a^2008.10.3126107Peony root (Yamato)PRNara, JapanTochimoto Tenkaido Co., Ltd., Osaka, JapanD10^a^2008.10.3126398Peony rootPRNagano, JapanNational Institute of Biomedical Innovation, JapanD41200927688Peony rootPRNara, JapanNational Institute of Biomedical Innovation, JapanD42201027694Peony rootPRNiigata, JapanNational Institute of Biomedical Innovation, JapanD43201027695Peony rootPRNara, JapanNational Institute of Biomedical Innovation, JapanD44201027698Peony rootPRJapanUchida Wakanyaku Co., Ltd., Tokyo, JapanD49^a^2012.09.0427891Red peony rootRPRSichuan, ChinaCenxi, Guangxi, ChinaD16^a^2008.09.0625974Red peony rootRPRInner Mongolia, ChinaChifeng, Inner Mongolia, ChinaD12^a^2002.09.1421565Red peony rootRPRInner Mongolia, ChinaBozhou, Anhui, ChinaD13^a^2006.05.0125047Red peony rootRPRChinaUchida Wakanyaku Co., Ltd., Tokyo, Japan*D14* ^a^2008.10.0726401Red peony rootRPRInner Mongolia, ChinaTochimoto Tenkaido Co., Ltd., Osaka, JapanD15^a^2008.10.1626406Red peony rootRPRChinaMatsuura Co., Ltd., Nagoya, JapanD54^a^2012.10.0427893Red peony root^b^RPR^b^Ganzi, Sichuan, ChinaGanzi, Sichuan, ChinaD11^a^1996.07.1117304^a^Samples used in chemical analysis; italicized number: multiple individuals in the sample were analyzed^b^This sample is derived from *P. veitchii*; apart from this sample the others are derived from *P. lactiflora* based on sequence analysis results

Genomic DNA extraction and PCR amplification {#Sec4}
--------------------------------------------

Total DNA was extracted from 50 − 60 mg of root powder by using DNeasy™ Plant Mini Kit (Qiagen, Germany) with little modification to the protocol provided by the manufacturer. The primer pair used for PCR amplification were ITS-1F (5′-GTA GGT GAA CCT GCA GAA GGA TCA-3′) and 18S-25S-3′R (5′-CCA TGC TTA AAC TCA GCG GGT-3′) as reported previously \[[@CR16]\], which was able to amplify a fragment of approximately 700 bp including the rDNA ITS1--5.8S--ITS2 regions. PCR amplification was performed in 25 µl of reaction mixture, consisting of 1 × PCR buffer for KOD-Plus-, 0.2 mM of each dNTP, 1.0 mM MgSO~4~, 0.3 μM of each primer, 0.5 U KOD-Plus- DNA polymerase (Toyobo, Japan), and 0.5 µl of total DNA. PCR amplification was performed under the cycling profile of a preliminary denaturation at 94 °C for 5 min, 35 cycles of 94 °C for 30 s, 55 °C for 30 s, and 68 °C for 50 s, and a final extension at 68 °C for 10 min by a Takara thermal cycler (Takara, Japan). PCR products were purified with a WizardSV PCR Clean-Up System (Promega, USA).

Sequence analysis and clustering analysis {#Sec5}
-----------------------------------------

Sequencing reaction of purified PCR products was carried out separately using ABI PRISM Bigdye Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems, USA) with each of the 4 types of primers (ITS-1F, 18S-25S-3′R, In-18S-25S-5′F: 5′-TCT CGC ATC GAT GAA GAA CG-3′ and In-18S-25S-3′R: 5′-GAC TCG ATG GTT CAC GGG ATT CT-3′). The sequence was determined directly using ABI Prism 3100-Avant Genetic Analyzer (Applied Biosystems, USA). With regard to the judgment of additive sites, we calculated the relative intensity of the lower peak as *S* value (lower peak intensity/sum of main peak intensity and lower peak intensity) for the sites where double peaks occurred. The sites with an *S* value no less than 15 % were recorded as additive sites, according to our previous results from experimental examinations \[[@CR17], [@CR18]\]. The borders of ITS1, 5.8S, and ITS2 regions were determined by comparison with the known sequences of mung bean and rice \[[@CR19], [@CR20]\]. The nucleotides sequence data of the ITS1--5.8S--ITS2 regions were deposited in the International Nucleotide Sequence Database (INSD: DDBJ/EMBI/NCBI) with the accession numbers shown in Table [3](#Tab3){ref-type="table"}.Table 3Comparison of ITS sequences among various samples derived from *Paeonia lactifloraK* = G&T; M = A&C; R = A&G; S = C&G; W = A&T; Y = C&TItalic numbers, plant materials; bold faced number, RPR produced in China; underlined numbers, PR produced in Japan

Comparison of ITS sequences was carried out by the ClastalW2 program for multiple sequence alignment. A guide tree on the basis of sequence similarity was constructed during multiple sequence alignment (<http://www.ebi.ac.uk/Tools/msa/clustalw2/>). Besides the sequences determined in the present study, ITS sequences of related *Paeonia* species obtained from INSD were also included.

HPLC analysis of 8 main components {#Sec6}
----------------------------------

Quantitative analysis of 8 main components (paeoniflorin, albiflorin, pentagalloylglucose \[PGG\], (+)-catechin, gallic acid, methyl gallate, benzoic acid and paeonol) (Fig. [1](#Fig1){ref-type="fig"}) was conducted using the reported method \[[@CR14], [@CR21]\] with little modification. Of the standards, paeoniflorin, albiflorin and paeonol were purchased from Wako Pure Chemical Industries (Osaka, Japan), PGG from Toronto Research Chemicals (ON, Canada), (+)-catechin from Cayman Chemical Company (MI, USA), gallic acid and benzoic acid from Nacalai Tesque Inc. (Japan), and methyl gallate from ChromaDex (CA, USA). Reagents for HPLC analysis including acetonitrile, distilled water (both of HPLC grade) and phosphatic acid (analytical grade) were purchased from Wako Pure Chemical Industries (Japan).Fig. 1Chemical structures of 8 compounds

A Jasco HPLC system equipped with a PU-1580 pump, an LC-1580-02 ternary gradient unit, and an MD-1510 multiple wavelength detector was used. Analysis was carried out using a YMC Pack AQ-303 (ODS, 4.6 mm i.d. × 250 mm, 5 μm) with column temperature at 27 °C. The mobile phase consisted of binary eluents of (A) 0.1 % (v/v) phosphatic acid and (B) CH~3~CN under gradient conditions (0 min, 10 % B; 5 min, 15 % B; 40 min, 30 % B; 45 min, 70 % B; 46 min, 80 % B; 50 min, 80 % B; 55 min, 10 % B; 65 min, 10 % B). Flow rate was 1.0 ml/min. Detection was performed at a wavelength of 232 nm.

Each standard was accurately weighed and dissolved in 75 % EtOH to make a stock solution of 1.0 mg/ml. To make calibration curves, a series of standard solutions (200, 100, 20, 10, 2 µg/ml) were prepared from the stock solution. The calibration curve of each component was prepared by plotting the peak areas against a series of injection amounts.

The respective samples (10--50 g) were pulverized and then screened through a 300-µm sieve to obtain homogeneous fine powder of each sample; 0.3 g of the fine powder was accurately weighed and extracted with 75 % EtOH (9 ml, 8 ml × 2) by ultrasonication at room temperature for 30 min, mixed periodically by vortex to obtain full extraction. The supernatant was then obtained by centrifugation at 2,500 rpm (Kubota 3740, Japan) for 10 min. Supernatants were combined into a 25.0-ml volumetric flask and finally filled with 75 % EtOH to the volume. After filtration through a 0.2-µm Millipore filter unit (Advantec, Japan), 20.0 µl of this solution was injected into the HPLC system for analysis.

The quantitative analysis data was further subjected to principal component analysis (PCA) by using software IBM SPSS Statistics (Version 19.0) to facilitate characterization of WPR and RPR.

Results and discussion {#Sec7}
======================

Genetic characterization based on ITS sequences {#Sec8}
-----------------------------------------------

The ITS sequences of specimens of the four *Paeonia* species as well as the crude drug samples were clearly determined and compared. All the sequences were of the same length, in which the ITS1 region was 267 bp, the 5.8S rRNA gene region was 164 bp, and the ITS2 region was 221 bp. The specimens of the 4 species showed their own ITS sequences which had \> 99 % homology to the corresponding sequences of the respective species registered in INSD. All the determined sequences were compared using ClastalW2, a program for multiple sequence alignment. The program constructed a guide tree (Fig. [2](#Fig2){ref-type="fig"}) on the basis of sequence similarity to facilitate the alignment. In this guide tree, *P. lactiflora* formed a large group which was completely separate from *P. veitchii*, *P. anomala*, *P. japonica* and *P. suffruticosa*. Of the crude drug samples collected from markets, only a sample of RPR (D11) collected from Sichuan province presented an almost identical sequence to that of *P. veitchii* (P7) and was identified as *P. veitchii* (Fig. [2](#Fig2){ref-type="fig"}). Other samples which included both WPR and RPR were confirmed to be *P. lactiflora* based on the sequence similarity. Within the group of *P. lactiflora*, two main subgroups were further clustered (Fig. [2](#Fig2){ref-type="fig"}). It is noteworthy that the WPR produced in the southern parts of China belonged to one subgroup (WPR subgroup) and the RPR produced in the northern parts of China fell into another subgroup (RPR subgroup) (Fig. [2](#Fig2){ref-type="fig"}). The results clearly indicated that the ITS sequence was informative and sufficiently powerful to discriminate *Paeonia* plants at either inter-species or intra-species levels and suggested that WPR and RPR were geographically isolated and genetically separated.Fig. 2Guide tree obtained from multiple sequence alignment on the basis of sequence similarity. \*Italic numbers, plant materials; underlined numbers, PR produced in Japan

Within *P. lactiflora*, significant intra-species polymorphism of the ITS sequences was detected. Although Sang et al. \[[@CR7]\] reported that there was almost no polymorphism in the ITS sequence among intraspecific populations, the present study, by sampling dozens of accessions widely collected from China and Japan, indicated a significant polymorphism in the ITS sequences of *P. lactiflora*. Table [3](#Tab3){ref-type="table"} shows nucleotide differences among various types of ITS sequences from *P. lactiflora*-derived samples. The ITS sequences of *P. lactiflora* deposited in INSD included two main types, which differed from each other by three nucleotides at positions 69, 458 and 523 (Table [3](#Tab3){ref-type="table"}). Type 1 (U27682 reported by Sang et al. \[[@CR7]\] ) shows three cytosines (C--C--C), while type 2 (JN572150 reported by Sun and Hong \[[@CR22]\] ) has thymine, adenosine and thymine (T-A-T) at the three sites. According to the nucleotides at these three sites, the samples analyzed in the present study were divided into two main groups corresponding to the two subgroups as shown in Fig. [2](#Fig2){ref-type="fig"}. One subgroup which included all the samples of WPR produced in Anhui, Zhejiang and Sichuan provinces and the two Japanese medicinal cultivars (S31, S34) showed T~69~-A~458~-T~523~ at the same three sites as the type 2. The other subgroup which included plant specimens of wild *P. lactiflora* (P1--P3) as well as the RPR samples, except for sample D16 from Sichuan province, showed additive nucleotides (double nucleotides detected at the same site) as Y (T&C), M (A&C) and Y at the three sites (Y~69~-M~458~-Y~523~), respectively. Three PR samples (D6-2, D6-5, D8) with additive nucleotides at one or two of the three sites presented intermediate type of sequences.

Apart from the difference at the above three sites, nucleotide additivities were observed at another 17 positions (Table [3](#Tab3){ref-type="table"}). Due to the bi-parental inheritance mode of the nrDNA ITS region, nucleotide additivities detected in the sequence are potentially advantageous features for speculating hybridization and inferring progenitors and lineages \[[@CR7]\]. However, lineages other than *P. lactiflora* which are possibly involved and responsible for these nucleotide additivities could not be implied even through wide comparison of the ITS sequences from genus *Paeonia* registered in INSD. Future investigation around wild habitats of *P. lactiflora* and subsequent sequencing of related samples might provide further evidence. Among such sites, additivities detected at nucleotide positions 239 and 246 were found to be in common within the WPR subgroup, and those at position 93 were almost in common within the RPR subgroup. Detailed sequence comparison indicated that the divergent sites in the ITS sequence have the potential to discriminate between WPR and RPR; in particular, the nucleotides at positions 69, 458 and 523 were the most informative.

The two Japanese medicinal cultivars of *P. lactiflora*---'Bonten' (S34) and 'Kitasaisho' (S31)---showed the same sequence which was identical to a type of sequence from WPR (AB920144, Table [3](#Tab3){ref-type="table"}). The PR produced in Nara prefecture which is usually called 'Yamato Shakuyaku' is believed to be derived from 'Bonten'; however, two samples (D9, D42) out of the five produced in Nara prefecture also belonged to the RPR subgroup, but not the WPR subgroup. Meanwhile, analysis of five individual samples which were randomly picked from a crude drug sample produced in Niigata prefecture (D6-1--5) achieved five types of ITS sequences; however, none were the same as the Japanese medicinal cultivars. Such sequences were detected in diverse horticultural cultivars of *P. lactiflora* (unpublished data), which suggested that PR from Japanese markets included not only roots of the medicinal cultivars but also roots of the horticultural cultivars of *P. lactiflora*.

Chemical comparison on the basis of quantitation of 8 main components {#Sec9}
---------------------------------------------------------------------

The contents of 8 main components were quantitatively analyzed to clarify the chemical properties of *P. lactiflora*, *P. veitchii*, *P. anomala*, and the crude drug samples including WPR, PR and RPR. Within the commercial samples derived from *P. lactiflora*, the RPR samples produced in the northern parts of China had an obviously higher content of paeoniflorin and paeonol, but a lower content of albiflorin than WPR/PR produced in the southern parts of China and most of the PR produced in Japan. Among the 11 commercial samples of WPR collected from various places in China, eight samples contained \< 20 mg/g of paeoniflorin. In particular, the three samples (D18, D22, D24) had extremely low content of paeoniflorin (\< 1.5 mg/g). When the HPLC chromatograms of these 3 samples were compared with others, a conspicuous peak with a retention time at approximately 10.4 min was commonly observed in these 3 samples, which was not detected in the PR collected from the Japanese markets. Wang et al. \[[@CR14]\] reported that an artifact compound, paeoniflorin sulphonate, could be detected in WPR which has been processed by sulfur fumigation (a traditional process for crude drugs in traditional Chinese medicine). Further analysis using LC/MS clearly indicated this notable peak was paeoniflorin sulphonate (data not shown). In the HPLC chromatograms of more than half of the WPR collected from Chinese markets (indicated in Fig. [3](#Fig3){ref-type="fig"}), the paeoniflorin sulphonate peak was detected. This result indicated that the WPR available from Chinese markets was usually processed by sulfur fumigating which resulted in an extremely low content of paeoniflorin; however, the PR available from Japanese markets did not undergo this process (Table [4](#Tab4){ref-type="table"}).Fig. 3Contents of 8 compounds in WPR, PR and RPR derived from *P. lactiflora*. \*WPR which was processed by sulfur fumigation. D16 was purchased in Guangxi, China as RPR; however, genetic analysis indicated it belonged to the WPR subgroup. Therefore we placed it within the WPR group. ^▲^P9 and P1 were collected in Zhejiang and Inner Mongolia, respectively, where are the production areas of WPR and RPRTable 4Contents of 8 compounds in *Paeonia* species and crude drug samples of WPR, PR and RPRCode no.![](11418_2014_857_Figa_HTML.gif){#d30e2283} Content (mg/g)PaeoniflorinAlbiflorinPGGGallic acidCatechinBenzoic acidPaeonolMethylgallateD123.394.072.570.890.260.32NDNDD216.003.411.910.39ND2.200.02NDD328.293.433.601.140.240.60NDTraceD1720.215.333.310.980.300.34NDNDD239.125.923.720.910.460.13NDNDD437.5810.3610.511.600.401.39NDNDD1618.825.218.372.15Trace0.720.05NDD181.114.932.720.970.530.26TraceNDD220.533.162.050.880.530.17NDNDD2918.484.963.520.530.570.20NDNDD241.215.873.871.600.680.17NDNDP9-124.814.775.710.840.290.68NDNDP9-223.9019.664.390.571.031.63NDNDP9-320.021.475.111.390.230.20NDNDD4527.543.735.091.210.220.28NDNDD4634.422.777.380.95Trace1.200.03NDD4743.4613.059.601.660.481.90NDNDD4840.325.736.691.020.211.08NDNDD5329.243.297.291.38Trace2.03NDNDD5021.171.819.351.750.161.12NDNDD5122.103.788.871.88ND1.08NDNDD5221.825.287.441.57ND1.21NDNDD1029.972.675.831.000.331.28NDNDD726.450.485.341.10ND1.47NDNDD827.363.702.660.460.321.13NDNDD633.423.804.100.810.431.12TraceNDD941.994.113.750.771.240.76NDNDD4930.492.335.721.080.341.37TraceNDP154.652.892.510.573.730.880.11NDD1269.272.275.800.601.050.900.32NDD1364.941.472.380.55Trace0.900.14NDD1553.641.224.390.631.751.230.23NDD1439.431.047.180.800.710.910.05NDD5435.320.533.630.480.910.820.27NDP761.920.6435.454.79ND1.01NDNDD1171.360.6938.329.79ND0.82ND0.78P48.422.6511.082.25ND0.68NDNDP513.000.2411.291.62ND0.790.01NDP615.620.2816.562.51ND0.81NDNDND, not detected; trace, lower than limit of quantitation

The root of *P. veitchii* (P7), as well as the RPR sample derived from this species (D11) showed the highest content of paeoniflorin (6.19--7.14 %), PGG (3.55--3.83 %) and gallic acid (0.48--0.98 %), and clearly differed from the samples derived from *P. lactiflora*. In particular, the contents of PGG as well as gallic acid were twice as high as those in other species. Such characteristics in the chemical composition have been supported by the reported data \[[@CR21]\]. In the roots of *P. anomala* (P4--P6), the content of paeoniflorin was very low and catechin was not detected.

Apart from the WPR samples which were thought to be processed by sulfur fumigation, the quantitative data of the 6 main compounds in *Paeonia* specimens and commercial samples were subjected to PCA analysis in order to compare the chemical characteristics of WPR and RPR derived from *P. lactiflora*, as well as the related species. The PCA scores plot is shown in Fig. [4](#Fig4){ref-type="fig"}a, where the first and second principal components accounted for 65.3 % of the total variance (PC1, 37.1 %; PC2, 28.2 %). The PCA loading plot (Fig. [4](#Fig4){ref-type="fig"}b) indicated that compounds **3** and **5** contributed much to the positive value of PC1, and compounds **1** and **4**--**6** contributed much to the positive value of PC2. The distribution of all the samples in the PCA scores plot (Fig. [4](#Fig4){ref-type="fig"}a) showed that four separated groups were clustered. Besides the respective groups of *P. veitchii* and *P. anomala*, samples derived from *P. lactiflora* were clearly classified into two groups---one group included RPR and the other group was composed of WPR, PR produced in China and most of the PR produced in Japan. By comparing the scores plot and loading plot, the characteristic chemical composition of the respective groups could be easily observed. The *P. veitchii* group which was different from other groups had a significantly high content of paeoniflorin, PGG and gallic acid. The RPR group had an obviously high content of paeonol, catechin and paeoniflorin, while the WPR/PR group had a relatively high content of albiflorin. Moreover, the grouping result in the PCA scores plot was in accordance with the clustering result based on the similarity of ITS sequences.Fig. 4Principal component analysis of chemical component data from *Paeonia* specimens and peony root samples. **a** Scores plot, *filled circle* WPR produced in China and P9-2, *open circle* PR produced in China, *filled triangle* PR produced in Japan, *filled square* RPR in Chinese market and P1, *open square* RPR in Japanese market. Above are *P. lactiflora*. *Plus symbol*, *P. anomala*; *filled diamond*, *P. veitchii*. **b** Loading plot; **1** paeoniflorin, **2** albiflorin, **3** PGG, **4** (+)-catechin, **5** gallic acid, **6** paeonol

Conclusion {#Sec10}
==========

The present study determined the nucleotide sequence of the ITS region and conducted quantitative analysis of 8 main chemical components of four *Paeonia* species, as well as commercial samples of WPR, PR and RPR collected from Chinese and Japanese markets. The ITS sequence was informative and sufficiently powerful to discriminate *Paeonia* plants at either inter-species or intra-species levels. Significant intra-species polymorphism of the ITS sequences was detected within *P. lactiflora*. Clustering analysis based on the ITS sequences of the samples showed that *P. lactiflora* formed a group which was completely separate from other *Paeonia* species. Within the *P. lactiflora* group, the WPR and PR produced in the southern parts of China and the RPR produced in the northern parts of China were clearly clustered into two subgroups. The nucleotides at positions 69, 458 and 523 upstream of the ITS sequence served as molecular markers to discriminate between WPR and RPR. The medicinal cultivars 'Bonten' and 'Kitasaisho', as well as half of the PR produced in Japan belonged to the WPR subgroup. Quantitative analysis of 8 main components clarified the chemical properties of three *Paeonia* species as well as the WPR and RPR derived from *P. lactiflora*. The root of *P. veitchii* and its derived RPR sample showed the highest content of paeoniflorin, PGG and gallic acid, which clearly differed from those derived from *P. lactiflora*. As for the samples derived from *P. lactiflora*, the RPR samples produced in the northern parts of China had an obviously higher content of paeoniflorin and paeonol, but a lower content of albiflorin than the WPR and PR produced in the southern parts of China and the PR produced in Japan. Chemical analysis indicated that the WPR available in Chinese markets was usually processed by sulfur fumigation, which resulted in an extremely low content of paeoniflorin. The present study indicated that WPR and RPR were not only geographically isolated, but also genetically and chemically separated. The ITS sequence provided a genetic index for their identification.
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